Risk of further ulcer complications after an episode of peptic ulcer bleeding

British Journal of Surgery

Volumn 83, Issue 6, 1996, Pages 840-844

  Ng, E K W ^a   Chung, S C S ^a   Lau, J T F ^a   Sung, J J Y ^a   Leung, J W C ^a   Raimes, S A ^a   Chan, A C W ^a   Li, A K C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; DUODENUM ULCER; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SEX; SMOKING; STOMACH ULCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DUODENAL ULCER; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIC ULCER HEMORRHAGE; PROGNOSIS; RECURRENCE; RISK FACTORS; STOMACH ULCER; TIME FACTORS;

EID: 0029884792     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830635     Document Type: Article

References (30)

1. Paterson WL. Bleeding peptic ulcer. Epidemiology and nonsurgical management. Gastroenterol Clin North Am 1990; 19: 155-70.
2. Feldman M, Burton ME. Histamine 2-receptor antagonists. Standard therapy for acid-peptic diseases, (2). N Engl J Med 1990; 323: 1749-55.
3. Bornman PC, Theodorou NA, Shuttleworth RD, Essel HP, Marks IN. Importance of hypovolaemic shock and endoscopie signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation. BMJ 1985; 291: 245-7.
4. Griffiths WJ, Neumann DA, Welsh JD. The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage. N Engl J Med 1979; 300: 1411-13.
5. Wara P. Endoscopic prediction of major rebleeding - a prospective study of stigmata of hemorrhage in bleeding ulcer. Gastroenterology 1985; 88: 1209-14.
6. Jensen DM, Cheng S, Kovacs TO et al. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994; 330: 382-6.
7. Northfield TC. Factors predisposing to recurrent haemorrhage after acute gastrointestinal bleeding. BMJ 1971; 1: 26-8.
8. Bardhan KD. Refractory duodenal ulcer. Gut 1984; 25: 711-17.
9. Massarrat S, Eisenmann A. Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment. Gut 1981; 22: 97-102.
10. Sun DCH, Stempien SJ. Site and size of the ulcer as determinants of outcome. Veterans Administration cooperative study on gastric ulcer. Gastroenterology 1971; 61: 576-84.
11. Gudmand Hoyer E, Jensen KB, Krag E et al. Prophylactic effect of cimetidine in duodenal ulcer disease. BMJ 1978; 1: 1095-7.
12. Langman MJS. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology 1989; 96(Suppl.): 640-6.
13. Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82: 1153-8.
14. Graham DY, Smith JL. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988; 83: 1081-4.
15. Skander MP, Ryan FP. Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. BMJ 1988; 297: 833-4.
16. Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489-92.
17. Piper DW, McIntosh JH, Hudson HM. Factors relevant to the prognosis of chronic duodenal ulcer. Digestion 1985; 31: 9-16.
18. Sontag S, Graham DY, Belsito A et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med 1984; 311: 689-93.
19. Ippoliti A, Elashoff J, Koretz R et al. Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology 1983; 85: 875-80.
20. Murthy SNS, Dinoso VP Jr, Clearfield HR, Chey WY. Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology 1977; 73: 758-61.
21. Brown P. The influence of smoking on pancreatic function in man. Med J Aust 1976; 2: 290-3.
22. Walker V, Taylor WH. Cigarette smoking, chronic peptic ulceration, and pepsin 1 secretion. Gut 1979; 20: 971-6.
23. Sung JJ, Chung SC, Ling TK et al. One-year follow-up of duodenal ulcers after 1-wk therapy for Helicobacter pylori. Am J Gastroenterol 1994; 89: 199-202.
24. Hosking SW, Ling TK, Yung MY et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ 1992; 305: 502-4.
25. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
26. Hosking SW, Ling TKW, Chung SCS et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
27. National Institutes of Health, Office of the Director. Helicobacter pylori in peptic ulcer disease. NIH Consensus Statement 1994; February 7-9; 12: 1-22.
28. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
29. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
30. Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammer C-H. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41: 5-7.